Veye Chest

Aidence

Source: https://www.aidence.com/
This AI assistant supports radiologists with detecting, reporting and tracking of pulmonary nodules. Integrated in the PACS, Veye Chest is trained with 45.000 chest scans. It is currently in use across Europe in both routine clinical practice and lung cancer screening programmes.
Product specifications Information source: Vendor
Last updated: Feb. 13, 2020
General
Product name Veye Chest
Company Aidence
Subspeciality Chest
Modality CT
Disease targeted Lung cancer
Key-features Nodule detection, nodule classification, volume quantification, growth calculation (prior study retrieval)
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion
Data characteristics
Population
Input low or standard dose CT scans, maximum axial slice thickness of 3mm, non-contrast or post-contrast, multi-slice
Input format DICOM
Output image annotations, grayscale presentation state (GSPS), burn-in series, table of quantified values
Output format DICOM, PDF
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 1 - 10 minutes
Certification
CE Certified, Class IIa
FDA No or not yet
Market presence
On market since 12-2017
Distribution channels Nuance, Incepto
Countries present (clinical, non-research use) 6
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use
Based on Number of scans analysed
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers